Gene7 Biotech Private Limited, a struck off private limited company, was established on 02 January 2012 in Hyderabad, Telangana, India. Engaging in animal feeds within the agriculture sector, it holds CIN: U51497TG2012PTC078357. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a active non-compliant status. Its leadership includes Sambashiva Rao Makkapatt (Whole-Time Director), Kishore Babu Turlapati (Whole-Time Director), Mallikharjuna Rao Kongara (Whole-Time Director). Past directors included Sambashiva Rao Makkapatt, Kishore Babu Turlapati, Ravi Kumar Gottipati. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at H No:5-9-234/1, P No:8, 1St Floor, Rajiv Randhi Na Gar, Prashanti Nagar, Kukatpally, Hyderabad, Telangana, 500072.
U51497TG2012PTC078357
078357
02 January 2012
₹1.00 M
₹1.00 M
Roc Hyderabad
Unlisted
Struck Off
Explore comprehensive insights into Gene7 Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sambashiva Rao Makkapatt | Whole-Time Director | 02 Jan 2012 | Current |
| Kishore Babu Turlapati | Whole-Time Director | 02 Jan 2012 | Current |
| Mallikharjuna Rao Kongara | Whole-Time Director | 02 Jan 2012 | Current |
| Suresh Battula | Whole-Time Director | 02 Jan 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Feb 2014 | Past |
| Pramod Abcsdd | Director | 27 Feb 2014 | Past |
| Pramod Abcsdd | Whole-Time Director | 15 Dec 2014 | Past |
| Pramod Abcsdd | Director | 27 Feb 2014 | Past |
| Pramod Abcsdd | Director | 27 Feb 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gene7 Biotech Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 2.51% decrease. The company also saw a substantial improvement in profitability, with a 59.31% increase in profit. The company's net worth dipped by a decrease of 4.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Gene7 Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Gene7 Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gene7 Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gene7 Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gene7 Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was documented.
The activity Gene7 Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad. was completed.
The activity Sambashiva Rao Makkapatt was appointed as a Whole-time director was appointed as a Whole-time director on 02 Jan 2012 & has been associated with this company since 13 years 11 months . was completed.
Progress on Kishore Babu Turlapati was appointed as a Whole-time director was appointed as a Whole-time director on 02 Jan 2012 & has been associated with this company since 13 years 11 months . was documented.
Progress on Mallikharjuna Rao Kongara was appointed as a Whole-time director was appointed as a Whole-time director on 02 Jan 2012 & has been associated with this company since 13 years 11 months . was documented.
Progress on Suresh Battula was appointed as a Whole-time director was appointed as a Whole-time director on 02 Jan 2012 & has been associated with this company since 13 years 11 months . was documented.
The CIN of Gene7 Biotech Private Limited is U51497TG2012PTC078357.
Gene7 Biotech Private Limited is headquartered at H No:5-9-234/1, P No:8, 1St Floor, Rajiv Randhi Na Gar, Prashanti Nagar, Kukatpally, Hyderabad, Telangana, 500072.
Gene7 Biotech Private Limited was incorporated on 02 January 2012.
The current directors of Gene7 Biotech Private Limited are
The primary industry of Gene7 Biotech Private Limited is Agriculture.
Gene7 Biotech Private Limited is unlisted.
The authorized capital of Gene7 Biotech Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Gene7 Biotech Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX